IL6 and colitis: Furthermore, some studies showed that the protective effect of ginsenoside Rd on TNBS-induced recurrent colitis might be realized by regulating the activation of JNK and p38, reducing leukocyte aggregation, and downregulating the expression of TNF-α, IL-1β, IL-6, and other pro-inflammatory cytokines [57].